Gilead Presents New Data from Antiviral Development Programs at IDWeek 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Gilead Sciences (NASDAQ: GILD) | Delayed: 165.61 +6.41 (4.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $159.20 | 52 Week High | $108.63 | |||
| Open | $162.89 | 52 Week Low | $71.39 | |||
| Day High | $165.70 | P/E | 91.50 | |||
| Day Low | $160.86 | EPS | $1.81 | |||
| Volume | 8,429,033 | |||||
